Daily administration of low molecular weight heparin increases Hepatocyte Growth Factor serum levels in gynaecological patients: pharmacokinetic parameters and clinical implications

Daily administration of low molecular weight heparin increases Hepatocyte Growth Factor serum levels in gynaecological patients: pharmacokinetic parameters and clinical implications

<p>Abstract</p> <p>Background</p> <p>Hepatocyte Growth Factor (HGF) enhances cytotoxicity of paclitaxel (PTX) and cisplatin (CDDP) in human ovarian cancer cells. Because of potential pitfalls of HGF exogenous administration, we investigated whether HGF serum concentrati...

Full description

Bibliographic Details
Main Authors: Surbone Anna, Fuso Luca, Passera Roberto, Ferrero Annamaria, Marchese Cristiana, Martino Cosimo, Luchin Annalisa, Di Renzo Maria, Zola Paolo
Format: Article
Language:English
Published: BMC 2012-09-01
Series:BMC Research Notes
Subjects:
HGF
LMWH
Pharmacokinetics
Nadroparin
Epithelial ovarian cancer
Online Access:http://www.biomedcentral.com/1756-0500/5/517

Internet

http://www.biomedcentral.com/1756-0500/5/517

Similar Items